| Hans-Günter Meyer-Thompson | Verschiedenes
Study identifies a brain pathway involved in drug relapse after cessation of contingency management
Study identifies a brain pathway involved in drug relapse after cessation of contingency management
A team of researchers at the National Institute on Drug Abuse (NIDA) has identified what may be the crucial brain circuit involved in relapse to drug use when an effective behavioral treatment for drug addiction, known as contingency management, is discontinued. Contingency management uses non-drug rewards, such as cash stipends, prizes, or coupons for retail goods, to encourage people to remain drug-free. Most patients, however, will relapse when they no longer receive the alternative reward. (NIH-NIDA, Science Spotlight, 11.10.2017)